Wei-Ling Yan - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 2, 2021

Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case reportWei-Ling Yan, Shi-Long Yang, Fen-Ying Zhao, et al.

Paediatric Drugs|June 7, 2023

Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the LiteratureWei-Ling Yan, Fen-Ying Zhao, Min-Er Gu, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 2, 2021

Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case reportWei-Ling Yan, Shi-Long Yang, Fen-Ying Zhao, et al.

Paediatric Drugs|June 7, 2023

Ruxolitinib Treatment of Steroid-Refractory Graft-versus-Host Disease in Children: A Case Series and Review of the LiteratureWei-Ling Yan, Fen-Ying Zhao, Min-Er Gu, et al.

Pageof 1